Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does REMDESIVIR Cause Atrioventricular block second degree? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Atrioventricular block second degree have been filed in association with REMDESIVIR (Veklury). This represents 0.1% of all adverse event reports for REMDESIVIR.

14
Reports of Atrioventricular block second degree with REMDESIVIR
0.1%
of all REMDESIVIR reports
0
Deaths
6
Hospitalizations

How Dangerous Is Atrioventricular block second degree From REMDESIVIR?

Of the 14 reports, 6 (42.9%) required hospitalization, and 3 (21.4%) were considered life-threatening.

Is Atrioventricular block second degree Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REMDESIVIR. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does REMDESIVIR Cause?

Off label use (1,092) Alanine aminotransferase increased (1,047) Death (808) Aspartate aminotransferase increased (713) Bradycardia (652) Acute kidney injury (605) Covid-19 (570) Drug ineffective (497) Liver function test increased (447) Respiratory failure (394)

What Other Drugs Cause Atrioventricular block second degree?

FINGOLIMOD (167) DILTIAZEM (76) BISOPROLOL (73) METOPROLOL (67) OMEPRAZOLE (64) AMLODIPINE (58) ASPIRIN (55) LACOSAMIDE (55) AMIODARONE (49) FLUOXETINE (44)

Which REMDESIVIR Alternatives Have Lower Atrioventricular block second degree Risk?

REMDESIVIR vs REMERON REMDESIVIR vs REMICADE REMDESIVIR vs REMIFENTANIL REMDESIVIR vs REMIMAZOLAM REMDESIVIR vs REMODULIN

Related Pages

REMDESIVIR Full Profile All Atrioventricular block second degree Reports All Drugs Causing Atrioventricular block second degree REMDESIVIR Demographics